KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Inventory (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Inventory for 17 consecutive years, with $2.7 billion as the latest value for Q4 2025.

  • On a quarterly basis, Inventory rose 5.2% to $2.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.7 billion, a 5.2% increase, with the full-year FY2025 number at $2.7 billion, up 5.2% from a year prior.
  • Inventory was $2.7 billion for Q4 2025 at Bristol Myers Squibb, down from $2.8 billion in the prior quarter.
  • In the past five years, Inventory ranged from a high of $3.3 billion in Q3 2024 to a low of $2.0 billion in Q1 2021.
  • A 5-year average of $2.5 billion and a median of $2.5 billion in 2023 define the central range for Inventory.
  • Peak YoY movement for Inventory: plummeted 31.14% in 2021, then soared 36.78% in 2024.
  • Bristol Myers Squibb's Inventory stood at $2.1 billion in 2021, then increased by 11.65% to $2.3 billion in 2022, then grew by 13.81% to $2.7 billion in 2023, then fell by 3.94% to $2.6 billion in 2024, then rose by 5.2% to $2.7 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Inventory are $2.7 billion (Q4 2025), $2.8 billion (Q3 2025), and $2.7 billion (Q2 2025).